Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. Vyluma, Inc.
CRL
•Vyluma, Inc.

Vyluma, Inc. – FDA CRL

Record Details

Vyluma, Inc. received a Complete Response Letter from the FDA for its New Drug Application (NDA) 217711 for atropine sulphate ophthalmic solution, 0.01%, intended for pediatric myopia treatment. The FDA cited a lack of substantial evidence of effectiveness, as required by 21 CFR 314.126, noting that the clinical studies, particularly the CHAMP study, did not support the drug's efficacy. Key clinical issues included the CHAMP study's failure to meet its pre-specified hierarchical testing procedure, significant and imbalanced missing data that introduced bias, and flawed statistical analyses of treatment effects. The FDA found that the company's post-hoc analyses could not overcome these fundamental deficiencies. Furthermore, submitted supportive studies were deemed insufficient, either due to short duration or lack of generalizability to the U.S. population, with one U.S. study (MTS1) failing to show efficacy for the 0.01% concentration. Additionally, a facility inspection revealed Current Good Manufacturing Practice (CGMP) deficiencies. To resolve these issues, Vyluma must provide new clinical data demonstrating effectiveness through adequate and well-controlled investigations. The involved manufacturing facility must also satisfactorily address all inspectional deficiencies, ensure CGMP compliance, and may undergo re-inspection and a Pre-Approval Inspection before the application can be reconsidered. Labeling comments are deferred until clinical and manufacturing issues are resolved.

Company
Vyluma, Inc.
Product type
NDA (New Drug Application)
Person
  • Nithila Duraisamy
View Company Profile

ID · 3f3284f0-d4d5-47fb-b81a-a5e479182f47

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vyluma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.